ArticleJournal of experimental & clinical cancer research : CR2026

Circular RNA-based HPV16 therapeutic vaccine elicits potent and durable antitumor immunity.

Rong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.